Herbal Antibiotics: Natural Alternatives for Treating Drug-Resistant Bacteria (75 page)

Yakubu, Clare Banoeng. “Nibima”: a wonder plant for malaria treatment for Ghana.
Eyes on Malaria
3 (online).
http://eyesonmalaria.org/nibima.html
.

Yeau, K. L., et al. The cardiotonic effect of a glycoside from
Cryptolepis buchanani
.
Yao Xue Xue Bao
10 (1963): 561–65.

Zhu, H., et al. Chemical compound review: cymopol. Entry on WikiGenes website at
http://wikigenes.org/e/chem/e/5386672.html
(accessed November 18, 2010).

Zhu, H., et al. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells.
Oxford J Life Sci Med Tox Sci
91, no. 1 (2006): 132–39.

Zhu, X. Y., et al. Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antinfective agents.
Bioorg Med Chem
15, no. 2 (2007): 686–95.

Aboulella, A. M., et al. Phytotherapeutic effects of
Echinacea purpurea
in gamma-irradiated mice.
J Vet Sci
8, no. 4 (2007): 341–51.

Anonymous. Echinacea: Monograph.
Altern Med Rev
6, no. 4 (2001): 411–14.

Binns, S. E., et al. Light-mediated antifungal activity of echinacea extracts.
Planta Med
66, no. 3 (2000): 241–14.

Birt, D. F. Echinacea in infection.
Am J Clin Nutr
87, no. 2 (2008): 488S–92S.

Brush, J., et al. The effect of
Echinacea purpurea
,
Astragalus membranaceus
and
Glycyrrhiza glabra
on CD69 expression and immune cell activation in humans.
Phytother Res
20, no. 8 (2006): 687–95.

Chaves, Fernando., et al. Effect of
Echinacea purpurea
(Asteraceae) aqueous extract on antibody response to
Bothrops asper
venom and immune cell response.
Rev Biol Trop Int J Trop Biol
55, no. 1 (2007): 113–19.

Facino, R. M., et al. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of echinacea extracts in the prevention of skin photodamage.
Planta Med
61, no. 6 (1995): 510–14.

Fuchikama, H., et al. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B.
Drug Metab Dispos
34, no. 4 (2006): 577–82.

Jurkstiene, V., et al. Compensatory reactions of immune sytem and action of purple coneflower (
Echinacea purpurea
(L.) Moench) preparations.
Medicina (Kaunas)
40, no. 7 (2004): 657–62.

Kim, L. S., et al. Immunological activity of larch arabinogalactan and echinacea: a preliminary, randomized, double-blind, placebo-controlled trial.
Altern Med Rev
7, no. 2 (2002): 138–49.

Kraus, G. A., et al. Synthesis and natural distribution of anti-inflammatory alkamides from echinacea.
Molecule
11, no. 10 (2006): 758–67.

LaLone, C. A., et al. Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells.
J Agric Food Chem
55, no. 18 (2007): 7314–22.

Lee, T.-T., et al. Flavonoid, phenol and polysaccharide content of
Echinacea purpurea
L. and its immunostimulant capacity in vitro.
Internl J Enviro Sci Dev
1, no. 1 (2010): 5–9.

McCann, D. A., et al. Cytokine- and interferon-modulating properties of
Echinacea
spp. root tinctures stored at –20 degrees C for 2 years.
J Interferon Cytokine Res
27, no. 5 (2007): 425–36.

Melchart, D., et al. Results of five randomized studies on the immunomodulatory activity of preparations of echinacea.
J Altern Complement Med
1, no. 2 (1995): 145–60.

Miller, Sandra C. Echinacea: a miracle herb against aging and cancer? Evidence
in vivo
in mice.
Evid Based Complement Alternat Med
2, no. 3 (2005): 309–14.

Mishima, S., et al. Antioxidant and immuno-enhancing effects of
Echinacea purpurea
.
Biol Pharm Bull
27, no. 7 (2004): 1004–9.

Pleschka, S., et al. Anti-viral properties and mode of action of standardized
Echinacea purpurea
extract against highly pathogenic avian influenza virus (H5N1, H5N7) and swine-origin H1N1 (S-OIV).
Virol J
13, no. 6 (2009): 197.

Raduner, S., et al. Alkylamides from echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects.
J Biol Chem
281, no. 20 (2006): 14192–206.

Rininger, J. A., et al. Immunopharmacological activity of echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells.
J Leukocyt Biol
68 (2000): 503.

Roesler, J., et al. Application of purified polysaccharides from cell cultures of the plant
Echinacea purpurea
to mice mediates protection against systemic infections with
Listeria monocytogenes
and
Candida albicans
.
Int J Immunopharmacol
13, no. 1 (1991): 27–37.

Romiti, N., et al. P-glycoprotein inhibitory activity of lipophilic constituents of
Echinacea pallida
roots in a human proximal tubular cell line.
Planta Med
74, no. 3 (2008): 264–66.

Rousseau, B., et al. Investigation of anti-hyaluronidase treatment on vocal fold wound healing.
J Voice
20, no. 3 (2006): 443–51.

Senchina, D. S., et al. Phenetic comparison of seven echinacea species based on immunomodulatory characteristics.
Econ Bot
60, no. 3 (2006):205–11.

Senchina, D. S., et al. Year-and-a-half old, dried echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination.
Planta Med
72, no. 13 (2006): 1207–15.

Sharma, M., et al. The potential use of echinacea in acne: control of
Propionibacterium acnes
growth and inflammation.
Phytother Res
25, no. 4 (2011): 517–21. E-pub (preprint) September 9, 2010.

Sharma, S. M., et al. Bactericidal and anti-inflammatory properties of a standardized echinacea extract (Echinaforce): dual actions against respiratory bacteria.
Phytomedicine
17, no. 8–9 (2010): 563–68.

Soudi, S., et al. Antileishmanial effect of
Echinacea purpurea
root extract cultivated in Iran.
Iran J Pharm Res
6, no. 2 (2007): 147–49.

Spence, Katherine M. In vivo evaluation of immunomodulatory properties of crude extracts of
Echinacea
species and fractions isolated from
Echinacea purpurea
. Master's thesis, University of Southern Queensland (Toowoomba, Queensland), 1999.
http://eprints.usq.edu.au/1512/
.

Steinmüller, C., et al. Polysaccharides isolated from plant cell cultures of
Echinacea purpurea
enhance the resistance of immunosuppressed mice against systemic infections with
Candida albicans
and
Listeria monocytogenes
.
Int J Immunopharmacol
15, no. 5 (1993): 605–14.

Stevenson, L. M., et al. Modulation of macrophage immune responses by echinacea.
Molecules
10 (2005): 1279–85.

Tamta, H., et al. Variability in in vitro macrophage activation by commercially diverse bulk echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharides.
J Agric Food Chem
56, no. 22 (2008): 10552–56.

Tunnerhoff, F. H., et al. Research in man and animal on the effect of echinacea extracts on artificial formation of connective tissues after fibrin implantations.
Arzneimittelforschung
6, no. 6 (1956): 330–34.

Wagner, H., et al. Immunostimulant action of polysaccharides (heteroglycans) from higher plants. Preliminary communication.
Arzneimittelforschung
34, no. 6 (1984): 659–61.

Wagner, H., et al. Immunostimulating action of polysaccharides (heteroglycans) from higher plants.
Arzneimittelforschung
35, no. 7 (1985): 1069–75.

Wang, C. Y., et al. Genomics and proteomics of immune modulatory effects of a butanol fraction of
Echinacea purpurea
in human dendritic cells.
BMC Genomics
13, no. 9 (2008): 479.

Zaporozhets, O. A., et al. Medicinal plants: spectrophotometric determination of hydroxycynnamic acid and related compounds in echinacea preparations.
Pharmaceutical Chem J
37, no. 12 (2003): 632.

Zhai, Z., et al. Alcohol extract of
Echinacea pallida
reverses stress-delayed wound healing in mice.
Phytomedicine
16, no. 6–7 (2009): 669–78.

Zhai, Z., et al. Alcohol extracts of echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro.
Food Agric Immunol
18, no. 3–4 (2007): 221–36.

Zhai, Z., et al. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation.
J Ethnopharmacol
122, no. 1 (2009): 76–85.

Zhai, Z., et al. Enhancement of innate and adaptive immune functions by multiple
Echinacea
species.
J Med Food
10, no. 3 (2007): 423–34.

Zwickey, H., et al. The effects of
Echinacea purpurea
,
Astragalus membranaceus
and
Glycyrrhiza glabra
on CD25 expression in humans: a pilot study.
Phytother Res
21, no. 11 (2007): 1109–12.

Anonymous. Eleutherococcus. Wikipedia.
http://en.Wikipedia.org/wiki/Eleutherococcus
(accessed December 9, 2010).

Anonymous.
Eleutherococcus pentaphyllus
. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database.
http://plants.usda.gov/java/profile?symbol=ELPE6
(accessed 12/9/2010).

Anonymous.
Eleutherococcus senticosus
. Entry in the Plants for a Future database.
http://pfaf.org/user/Plant.aspx?LatinName=Eleutherococcus+senticosus
(accessed January 24, 2008).

Anonymous.
Eleutherococcus senticosus.
Wikipedia.
http://en.Wikipedia.org/wiki/Eleutherococcus_senticosus
(accessed December 9, 2010).

Anonymous.
Eleutherococcus senticosus
: monograph.
Altern Med Rev
11, no. 2 (2006): 151–55.

Anonymous. Ginseng:
Eleutherococcus pentaphyllus
. State distribution map on the website of EDDMApS (Early Detection and Distribution Mapping System) at
http://eddmaps.org/distribution/usstate.cfm?sub=21019
(accessed December 9, 2010).

Arushanian, E. B., et al. Effect of eleutherococcus on short-term memory and visual perception in healthy humans.
Eksp Klin Farmakol
66, no. 5 (2003): 10–13.

Baczek, Katarzyna. Accumulation of biologically active compounds in eleuthero (
Eleutherococcus senticosus
/Rupr. Et Maxim./Maxim.) grown in Poland.
Herba Polonica
55, no. 1 (2009): 7–13.

Barenboim, G. M. Part V: Eleutherococcus and adaptogens: generalizations and hypotheses. Eleutherococcus: application and the mechanism of action. Available online on the website of VitaOffice at
http://vitaoffice.com/images/office/download/eleuthroandadaptogens.pdf
(accessed December 19, 2011).

Barenboim, G. M., and N. B. Kozlova. Part III: Eleutherococcus extract as an agent increasing the biological resistance of man exposed to unfavorable factors. Use of eleutherococcus extract for increasing the biological resistance of man exposed to different unfavourable environmental factors (a review). Available online on the website of VitaOffice at
http://vitaoffice.com/images/office/download/eleuthrobioresist.pdf
(accessed December 19, 2011).

Barenboim, G. M., and L. A. Protozanova. Part IV: Eleutherococcus extract: prospective trends in application. General methodological principles of the use of eleutherococcus extract for decreasing the effects of embryotoxic factors. Available online on the website of VitaOffice at
http://vitaoffice.com/images/office/download/eleuthrotrends.pdf
(accessed December 19, 2011).

Bocharov, E. V., et al. Neuroprotective features of phytoadaptogens.
Vestn Ross Akad Med Nauk
4 (2008): 47–50.

Cicero, A. F., et al. Effects of Siberian ginseng (
Eleutherococcus senticosus
Maxim.) on elderly quality of life: a randomized clinical trial.
Arch Gerentol Geriatr Suppl
9 (2004): 69–73.

Dardymov, I. V. Part II: Study of the mechanism of action of eleutherococcus extract. Some aspects of the mechanism of action of eleutherococcus extract. Available online on the website of VitaOffice at
http://vitaoffice.com/images/office/download/eleuthromechanism.pdf
(accessed December 19, 2011).

Davydov, M., et al.
Eleutherococcus senticosus
(Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look.
J Ethnopharmacol
72, no. 3 (2000): 345–93.

Deyama, T., et al. Constituents and pharmacological effects of
Eucommia
and Siberian ginseng,
Acta Pharmacol Sin
22, no. 12 (2001): 1057–70.

Donovan, J. L., et al. Siberian ginseng (
Eleutherococcus senticosus
) effects on CYP2D6 and CYP3A4 activity in normal volunteers.
Drug Metab Dispos
31, no. 5 (2003): 519–22.

Drozd, J., et al. Estimation of humoral activity of
Eleutherococcus senticosus
.
Acta Pol Pharm
59, no. 9 (2002): 395–401.

Feng, S., et al. Determination of eleutheroside E and eleutheroside B in rat plasma and tissue by high-performance liquid chromatography using solid-phase extraction and photodiode array detection.
Eur J Pharm Biopharm
62, no. 3 (2006): 315–20.